AMAL Therapeutics
- Health
Boehringer Ingelheim to Acquire Labor Dr. Merk & Kollegen to Strengthen its Next Generation Cancer Immunology Program
Ochsenhausen, Ingelheim am Rhein, Germany: Boehringer Ingelheim has signed the agreement on the acquisition of all shares of Germany-based biotech…
Read More »